Portfolio Update

RNS Number : 5723M
Intl. Biotechnology Trust PLC
27 August 2013
 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC      

                                                                                                                                   

                                                                                                                                              

Portfolio Update as at 31 July 2013                                                                                        

 

 

Total net assets

£176.3m

NAV per share

319.6p

Share price

268.8p

Total value of unquoted investments

£26.0m

Total number of portfolio companies

71

Cash

2% NAV

Cash committed and reserved to unquoted investments

(4.1%) NAV

 

                                                                                                                                              

Top Ten Holdings

                                                                                                                                                                                                                                                                    

Company Name

% NAV

Celgene

7.6

Biogen

7.4

Amgen

7.3

Gilead

7.3

Regeneron

6.7

Alexion

4.5

Aptiv

3.4

Vertex

3.1

Onyx

2.9

Incyte

2.6


-----------

Total

52.8

 

Geographical Allocation

%

United States & Canada

92

Europe

6

Cash

2


-----------

Total

100

 

                                                                                                                                                                                                                                                                    

Quoted/Unquoted allocation

%

Quoted

83

Unquoted

15

Cash

2


-----------

Total

100

                                                                                                   

 

BNP Paribas Secretarial Services Limited

Company Secretary

 

27 AUGUST 2013


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUBUGDICGDBGXR
UK 100

Latest directors dealings